Guming Holdings completed the issuance of HK$1.96 billion zero-coupon guaranteed convertible bonds on July 2, 2026, and will seek listing on the Vienna Stock Exchange. The net proceeds of approximately HK$1.9625 billion will be allocated with roughly 40% for share repurchases, 30% for debt repayment, 20% for raw materials and equipment procurement, and 10% for R&D and overseas expansion, to be fully utilized by June 30, 2027.
Brightstar Technology Group proposes a 20-for-1 share consolidation to maintain its authorized share capital at HK$30 million while reducing issued shares from 1.125 billion to approximately 56.3 million, with the board lot remaining at 2,000 shares. The move aims to address the share price trading below HK$0.15 and comply with GEM listing requirements, subject to shareholder and Stock Exchange approval, with an expected effective date of July 31, 2026.
Perfect Optronics expects to recognize an estimated fair value loss of approximately HK$4.34 million on its Mobvoi investment for the six months ended June 30, 2026, narrowing from a loss of HK$7.06 million in the same period last year. The fair value of its Mobvoi holdings dropped to approximately HK$5.58 million from HK$9.91 million at year-end, and the figures remain unaudited as consolidated results are being prepared.
By the close of trading on Jul 2, 2026, ALEBUND-B(09637.HK) saw a loss of 44.47% in its share price, closing at HKD 25.5. During the session, it reached an intraday high of HKD 39.04 and touched an intraday low of HKD 22.72.
By the close of trading on Jul 2, 2026, ANKER(00668.HK) saw a gain of 15.69% in its share price, closing at HKD 114.9. and touched an intraday low of HKD 90.
By the close of trading on Jul 2, 2026, KNOWLEDGE ATLAS(02513.HK) saw a loss of 16.64% in its share price, closing at HKD 1754. During the session, it reached an intraday high of HKD 2160 and touched an intraday low of HKD 1711.
MIDEA GROUP(00300.HK) will spend CNY 111.24 million to repurchase 1.44 million shares on Jul 2, 2026 .
NewTimeSpace News: By the close of trading on Jul 2, 2026, HJ SCIENCE-B(06132.HK) saw a gain of 15.38% in its share price, closing at HKD 41.4. During the session, it reached an intraday high of HKD 42.98 and touched an intraday low of HKD 34.6.
NewTimeSpace News: TENCENT(00700.HK) will spend HKD 500.8 million to repurchase 1.15 million shares on Jul 2, 2026.
NewTimeSpace News: CHINA LIT(00772.HK) will spend HKD 7.82 million to repurchase 400 thousand shares on Jul 2, 2026.
NewTimeSpace News: Soho Holly Futures Co., Ltd. (03678.HK) announced that following internal self-inspection, the Company is required to make supplementary payment of corporate property tax of RMB1,315,865.20 and late payment surcharges of RMB407,715.80, amounting to a total of RMB1,723,581.00. As of the date of this announcement, all such tax and surcharges have been fully settled, and no administrative penalties are involved.
NewTimeSpace News: China Vanke Co.,Ltd. (02202.HK) announced that upon nomination by the Chairman and review and approval by the Board of Directors, Mr. Huang Yu has been appointed as the President of the Company, with the term of office commencing on the date of the Board’s approval and expiring upon the end of the term of the 20th Board of Directors.
NewTimeSpace News: The United Laboratories International Holdings Ltd (03933.HK) announced that tadalafil tablets (specifications: 5mg, 10mg, 20mg) filed by Zhongshan Branch of Zhuhai United Laboratories, its wholly-owned subsidiary, have obtained marketing approval from the National Medical Products Administration, indicated for the treatment of erectile dysfunction and erectile dysfunction accompanied by benign prostatic hyperplasia.
NewTimeSpace News: Huajin International Holdings Limited (02738.HK) issued an announcement disclosing that after comprehensive verification, the Group has a total of 52 judicial equity freezing records covering 8 mainland China subsidiaries. All freezings stem from asset preservation applications filed by external third-party creditors over overdue outstanding debts. The Company emphasises that all freezing orders only apply to equity interests of mainland subsidiaries and will not impact the Company’s listed shares or daily business operations.
NewTimeSpace News: HUTCHMED (China) Limited (00013.HK) issued a voluntary announcement stating that ORPATHYS® (savolitinib), its proprietary oral MET inhibitor, has obtained conditional marketing approval from the National Medical Products Administration (NMPA) of China for adult patients with locally advanced or metastatic gastric or gastroesophageal junction (GC/GEJ) adenocarcinoma harbouring MET gene amplification, who have failed at least two lines of prior systemic therapy. This marks the third approved indication of savolitinib in China.
NewTimeSpace News: CSPC Pharmaceutical Group Limited (01093.HK) issued a voluntary announcement disclosing that the Group has entered into a collaboration, option and licence agreement with AstraZeneca. The parties will jointly develop preclinical candidate compounds (PCCs) targeting two therapeutic targets with potential for treating kidney diseases, leveraging the Group’s proprietary siRNA drug discovery platform and extrahepatic targeted delivery platform. CSPC will receive an upfront payment of USD30 million, plus potential development milestone payments of up to USD540 million, sales milestone payments of up to USD1.2 billion, and single-digit royalties on net annual sales of commercialised products.
